These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7203555)

  • 1. Variation in RNA tumor virus expression in H-2 congenic leukemia cell lines.
    Wolfe JH; Blank KJ; Pincus T
    Immunogenetics; 1981; 12(1-2):187-90. PubMed ID: 7203555
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural immunity to endogenous oncornaviruses in mice.
    Ihle JN; Hanna MG
    Contemp Top Immunobiol; 1977; 6():169-74. PubMed ID: 194747
    [No Abstract]   [Full Text] [Related]  

  • 3. Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus.
    Plata F; Lilly F
    J Exp Med; 1979 Nov; 150(5):1174-86. PubMed ID: 91655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigens induced by the mouse leukemia viruses.
    Pasternak G
    Adv Cancer Res; 1969; 12():1-99. PubMed ID: 4310621
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunizing and interfering action of non-leukemogenic C-type murine virus variants in leukemogenesis.
    Barski G; Youn JK
    Bibl Haematol; 1973; 39():370-6. PubMed ID: 4360168
    [No Abstract]   [Full Text] [Related]  

  • 6. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of H-2:H-7 congenic mice to study H-2-mediated resistance to Friend leukemia virus.
    Wettstein PJ; Blank KJ
    J Immunol; 1982 Jul; 129(1):358-61. PubMed ID: 7086137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo.
    Green WR
    J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for H-2-linked control of retrovirus production in Friend virus-induced tumor cell lines.
    Wolfe JH; Blank KJ
    J Virol; 1986 Jun; 58(3):782-9. PubMed ID: 3701928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization kinetics of friend and Rauscher leukemia viruses studied with the spleen focus assay method.
    Steeves RA; Axelrad AA
    Int J Cancer; 1967 May; 2(3):235-44. PubMed ID: 6041991
    [No Abstract]   [Full Text] [Related]  

  • 15. Leukemogenesis, immune responsiveness, and murine leukemia virus expression in congenic AKR/J mice differing at H-2.
    Johnson DA; Bedigian HG; Cherry M; Meier H
    Infect Immun; 1980 Sep; 29(3):1007-12. PubMed ID: 6253394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a variant of gross leukemia virus that induces disease in mice inoculated as adults.
    Wolfe JH; Blank KJ
    J Exp Med; 1983 Aug; 158(2):629-34. PubMed ID: 6886626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
    Longstreth JD; Ihle JN; Hanna MG
    Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
    [No Abstract]   [Full Text] [Related]  

  • 19. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes.
    Plata F; Tilkin AF; Lévy JP; Lilly F
    J Exp Med; 1981 Dec; 154(6):1795-810. PubMed ID: 6172533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.